AB1094 GUSELKUMAB EFFECT ON INFLAMMATORY CARDIOVASCULAR (CV) RISK BIOMARKERS, EFFICACY, AND SAFETY IN PSORIATIC ARTHRITIS PATIENTS WITH CV RISK FACTORS: POST-HOC ANALYSIS OF 2 PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES

Abstract

BackgroundPsA has been associated with an increased risk of cardiovascular disease (CVD), likely due to accelerated atherosclerosis secondary to chronic inflammation.[1] The number of CV risk factors has been shown...